- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02125370
Experiences of Pregnant Women Who Use NRT in Pregnancy as Part of a Quit Attempt
December 3, 2014 updated by: University of Nottingham
This study is largely a qualitative study with a small survey component.
The aim of the survey would be to gain a quantitative perspective of how women use NRT after this has been prescribed by stop smoking services (SSS).
The aim of the qualitative study would be to enhance knowledge of pregnant smoker's views and attitudes about their experiences of using NRT and in particular to understand why pregnant women who start using NRT often discontinue this early or do not use the medication as it is prescribed.
This information is important for a number of reasons; firstly it will help health professionals and researchers gain an in depth understanding about how women experience using NRT, which may be used to help devise strategies for encouraging better adherence and which could be used in future clinical trials to gain a clearer understanding as to whether or not NRT is effective in pregnancy.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
15
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Nottingham, United Kingdom
- New Leaf Stop smoking services
-
-
Nottinghamshire
-
Nottingham, Nottinghamshire, United Kingdom, NG7 2RD
- University of Nottingham
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Participants will be identified through two identification sites; New Leaf Stop Smoking Services in Nottinghamshire and Nottingham City.
The study will consist of a short survey focussing on how NRT is used during pregnancy.
As well as providing information the survey responses will also be able to distinguish who is eligible to participate in qualitative telephone interviews.
A subsection of these women will be asked to participate in an interview.
The survey and interviews will be conducted as close as possible after participants have had an appointment with a smoking cessation advisor and, have given consent for the researcher to contact them, this is likely to be within a two week period.
Description
Inclusion Criteria:
Quantitative survey;
- Women who are pregnant
- Aged 16 or over (no upper age limit)
- Who have been prescribed NRT (patches/dual therapy) to aid a quit attempt.
Qualitative interview study will include the above plus;
- Women will have used NRT for over 24 hours
- Either not be using NRT as prescribed (as deciphered by the survey questions) or have currently quit NRT (and have either stopped smoking or continue to smoke)
Exclusion Criteria:
Survey and qualitative interviews
- Women who cannot understand the study procedure sufficiently in order to provide consent e.g. due to cognitive difficulties
- Women who are unable to read or understand the consent procedure and study procedures in English.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Nicotine Replacement Therapy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
number of women that use NRT after being prescribed
Time Frame: within 4 weeks of taking part in the study
|
All women will be asked whether they have used NRT after being given a prescription, this measurement will be obtained within 4 weeks of the participant consenting to take part in the study.
|
within 4 weeks of taking part in the study
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of women who adhere to NRT
Time Frame: 4 weeks
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2014
Primary Completion (Actual)
December 1, 2014
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
April 23, 2014
First Submitted That Met QC Criteria
April 28, 2014
First Posted (Estimate)
April 29, 2014
Study Record Updates
Last Update Posted (Estimate)
December 4, 2014
Last Update Submitted That Met QC Criteria
December 3, 2014
Last Verified
December 1, 2014
More Information
Terms related to this study
Other Study ID Numbers
- 14024
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Meir Medical CenterRecruiting
-
Turku University HospitalUniversity of TurkuCompleted
-
Bagcilar Training and Research HospitalRecruitingEctopic PregnancyTurkey (Türkiye)
-
MELISA Institute Genomics & Proteomics Research...RecruitingHealthy | Pregnancy | Early Pregnancy | Early Pregnancy Loss | ChildbirthChile
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Rambam Health Care CampusUnknown
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
Clinical Trials on Qualitative and survey
-
Baylor Research InstituteNational Cancer Institute (NCI)Active, not recruiting
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker Cochin; Université de Cergy PontoiseCompleted
-
Kingston UniversityCompletedMajor TraumaUnited Kingdom
-
Dana-Farber Cancer InstituteNational Institutes of Health (NIH); Agency for Healthcare Research and Quality...Completed
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedBreast CancerUnited States
-
VA Office of Research and DevelopmentCompletedDiabetes | Self-Management | Diabetes Distress | VeteranUnited States
-
HaemnetHemab ApSCompletedVon Willebrand DiseasesUnited Kingdom
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Dartmouth-Hitchcock Medical Center; West Virginia... and other collaboratorsCompletedGynecologic Cancer | Thoracic Cancer | Gastrointestinal Cancer | Other CancerUnited States
-
The University of Hong KongUnknownSmoking CessationHong Kong
-
Cereneo AGcereneo Institute for Interdsciplinary Research (cefir)CompletedStroke | Diet Modification | RelativesSwitzerland